Valuation: Vitrolife AB

Market Cap 13.24B 1.34B 1.19B 1.1B 1B 1.88B 126B 1.91B 5.2B 66.41B 5.02B 4.92B 212B P/E 2026 *
26.5x
P/E 2027 * 20.8x
Enterprise Value 13.94B 1.41B 1.26B 1.16B 1.05B 1.98B 133B 2.01B 5.47B 69.9B 5.29B 5.18B 223B EV / Sales 2026 *
4.01x
EV / Sales 2027 * 3.55x
Free-Float
54.39%
Yield 2026 *
1.14%
Yield 2027 * 1.36%
1 day+0.05%
1 week-0.20%
Current month+2.84%
1 month+6.19%
3 months+10.32%
6 months-11.17%
Current year-28.61%
1 week 96.7
Extreme 96.7
99.65
1 month 89.6
Extreme 89.6
100.5
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 31/07/2023
Director of Finance/CFO 55 09/10/2025
Chief Operating Officer - 31/05/2026
Director TitleAgeSince
Director/Board Member 63 18/04/2013
Chairman 70 31/07/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap. Importance
06/02/26 Buy

Chief Operating Officer

6,470 0.0048%
06/02/26 Buy

Chief Executive Officer

3,013 0.0022%
04/02/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%-0.20%-31.56%-29.03% 1.34B
-1.89%-2.39%-21.19%+3.85% 174B
-2.23%+5.67%-21.63%+12.01% 114B
-1.69%-1.27%-2.92%+27.96% 114B
+15.48%+17.35%-45.10%+6.59% 89.64B
-0.83%+1.27%+3.53%+80.36% 64.96B
-0.32%+5.85%+14.72%+82.17% 56.09B
+0.28%+2.89%+2.81%-24.86% 52.94B
-0.80%+4.63%-13.13%+29.62% 43.6B
+0.29%+4.76%-7.20%-13.60% 32.77B
Average +0.83%+3.98%-12.17%+17.51% 74.33B
Weighted average by Cap. +0.71%+3.57%-13.69%+20.37%

Financials

2026 *2027 *
Net sales 3.48B 352M 313M 290M 263M 495M 33.19B 501M 1.37B 17.44B 1.32B 1.29B 55.59B 3.78B 382M 341M 315M 285M 538M 36.06B 544M 1.48B 18.96B 1.43B 1.4B 60.4B
Net income 498M 50.39M 44.91M 41.57M 37.62M 70.88M 4.76B 71.72M 196M 2.5B 189M 185M 7.97B 631M 63.81M 56.86M 52.65M 47.64M 89.76M 6.02B 90.83M 248M 3.17B 239M 234M 10.09B
Net Debt 694M 70.21M 62.56M 57.92M 52.42M 98.76M 6.63B 99.93M 273M 3.48B 263M 258M 11.1B 160M 16.12M 14.37M 13.3M 12.04M 22.68M 1.52B 22.95M 62.58M 800M 60.49M 59.23M 2.55B
Projected Income Statement - Annual - Vitrolife AB
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
21/10/26 SEK 97.80 +0.05% 65,340
20/10/26 SEK 97.75 -0.05% 96,601
19/10/26 SEK 97.80 -0.36% 77,477
16/10/26 SEK 98.15 -0.71% 79,262
15/10/26 SEK 98.85 +0.87% 229,824
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Vitrolife AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
97.80SEK
Average target price
131.20SEK
Spread / Average Target
+34.15%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Vitrolife AB
  1. Stock Market
  2. Stocks
  3. VITR Stock